Zenvia IPO

Made public by

sourced by PitchSend

36 of 39

Creator

Zenvia logo
Zenvia

Category

Healthcare

Published

2021

Slides

Transcriptions

#1Z·E····A IA INVESTOR PRESENTATION MAY 2021#2ISSUER SHARES OFFERED (BASE OFFER) GREENSHOE TICKER / LISTING PRICE RANGE ESTIMATED OFFER SIZE OFFERING BREAKDOWN USE OF PROCEEDS LOCK-UP FINANCIAL STATEMENTS GLOBAL COORDINATORS JOINT BOOKRUNNERS Zenvia Inc. ("Zenvia", "The Company" or Z.E.N.V.I.A) 12,909,091 Class A Common Shares (100% Primary) Up to 15% of Base Offer (1,936,364 Additional Class A Common Shares) ZENVI NASDAQ OFFERING SUMMARY USD 15.50-17.50 US$ 213mm @ mid-point of the range 100% primary Growth initiatives (including recent and new acquisitions) and general corporate purposes 180 Days Pricing with 2020 FY Financial Statements and pro forma unaudited financial statements giving effect to recent acquisitions Goldman Sachs Morgan Stanley bradesco Lead Left Bookrunner and Stabilization Agent XP Inc. Itaú UBS 2#3LEGAL DISCLAIMER THE INFORMATION CONTAINED IN THIS PRESENTATION IS CONFIDENTIAL INFORMATION. ACCORDINGLY, THE INFORMATION INCLUDED HEREIN MAY NOT BE REFERRED TO, QUOTED OR OTHERWISE DISCLOSED BY YOU. IN REVIEWING THIS INFORMATION, YOU ARE ACKNOWLEDGING THE CONFIDENTIAL NATURE OF THIS INFORMATION AND ARE AGREEING TO ABIDE BY THE TERMS OF THIS DISCLAIMER. THIS CONFIDENTIAL INFORMATION IS BEING MADE AVAILABLE TO EACH RECIPIENT SOLELY FOR ITS INFORMATION AND IS SUBJECT TO AMENDMENT. This presentation is prepared by Zenvia Inc. (the "Company," "we" or "our"). The Company has filed a registration statement (including a prospectus) with the Securities and Exchange Commission (the "SEC") for the offering to which this presentation relates. Before you invest, you should read the prospectus in that registration statement and other documents that the Company has filed with the SEC for more complete information about the Company and this offering. You may get these documents for free by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, copies of the prospectus related to the offering may be obtained, when available, from (i) Goldman Sachs & Co. LLC, Attention: Prospectus Department at 200 West Street, New York, NY 10282, or by telephone at +1-212-902-1171, facsimile: +1-212-902-9316, or by email at [email protected]; (ii) Morgan Stanley & Co. LLC, Attention: Prospectus Department at 1585 Broadway, New York, NY 10036, or by email at [email protected]; . Any offering of securities by the Company will only be made by means of a registration statement (including a prospectus) filed with the SEC, after such registration statement becomes effective. No such registration statement has become effective as of the date of this presentation. This presentation does not constitute a prospectus and shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction. In addition, this document and any materials distributed in connection with this presentation are not directed to, or intended for distribution to or use by, any person or entity that is a citizen or resident or located in any locality, state, country or other jurisdiction where such distribution, publication, availability or use would be contrary to law or regulation or which would require any registration or licensing within such jurisdiction. This presentation is private and confidential. You and your directors, officers, employees, agents and affiliates must hold this presentation and any oral information provided in connection with this presentation in strict confidence and may not communicate, reproduce, distribute or disclose it to any other person, or refer to it publicly, in whole or in part at any time except with our prior written consent. If you are not the intended recipient of this presentation, please delete and destroy all copies immediately. This presentation was prepared by the Company. Neither the Company nor any of its affiliates, officers, employees or agents, make any representation or warranty, express or implied, in relation to the fairness, reasonableness, adequacy, accuracy or completeness of the information, statements or opinions, whichever their source, contained in this presentation or any oral information provided in connection herewith, or any data it generates and accept no responsibility, obligation or liability (whether direct or indirect, in contract, tort or otherwise) in relation to any of such information. The information and opinions contained in this presentation are provided as at the date of this presentation, are subject to change without notice and do not purport to contain all information that may be required to evaluate the Company. The information in this presentation is in draft form and has not been independently verified. The Company and its affiliates, officers, employees and agents expressly disclaim any and all liability which may be based on this presentation and any errors therein or omissions therefrom. Neither the Company nor any of its affiliates, officers, employees or agents makes any representation or warranty, express or implied, that any transaction has been or may be effected on the terms or in the manner stated in this presentation, or as to the achievement or reasonableness of future projections, management targets, estimates, prospects or returns, if any. 3#4LEGAL DISCLAIMER (CONT'D) The information contained in this presentation does not purport to be comprehensive and has not been subject to any independent audit or review. A significant portion of the information contained in this presentation is based on estimates or expectations of the Company, and there can be no assurance that these estimates or expectations are or will prove to be accurate. The Company's internal estimates have not been verified by an external expert, and the Company cannot guarantee that a third party using different methods to assemble, analyze or compute market information and data would obtain or generate the same results. Statements in the presentation, including those regarding the possible or assumed future or other performance of the Company or its industry or other trend projections, constitute forward-looking statements. These statements are generally identified by the use of words such as "anticipate," "believe," "could," "expect," "should," "plan," "intend," "estimate" and "potential," among others. By their nature, forward-looking statements are necessarily subject to a high degree of uncertainty and involve known and unknown risks, uncertainties, assumptions and other factors because they relate to events and depend on circumstances that will occur in the future whether or not outside the control of the Company. Such factors may cause actual results, performance or developments to differ materially from those expressed or implied by such forward-looking statements and there can be no assurance that such forward-looking statements will prove to be correct. Accordingly, you should not place undue reliance on forward-looking statements. The forward-looking statements included herein speak only as at the date of this presentation and the Company does not undertake any obligation to update these forward-looking statements. Past performance does not guarantee or predict future performance. Moreover, the Company and its affiliates, officers, employees and agents do not undertake any obligation to review, update or confirm expectations or estimates or to release any revisions to any forward-looking statements to reflect events that occur or circumstances that arise in relation to the content of the presentation. We urge you to read the prospectus (filed as part of the registration statement on Form F-1 filed by the Company with the SEC (Registration No. 333-[-]), as amended), including the uncertainties and factors discussed under "Risk Factors" and "Cautionary Statement Regarding Forward- Looking Statements," completely and with the understanding that actual future results may be materially different from expectations. Market data and industry information used throughout this presentation are based on management's knowledge of the industry and the good faith estimates of management. The Company also relied, to the extent available, upon management's review of industry surveys and publications and other publicly available information prepared by a number of third party sources. All of the market data and industry information used in this presentation involves a number of assumptions and limitations, and you are cautioned not to give undue weight to such estimates. Although the Company believes that these sources are reliable, there can be no assurance as to the accuracy or completeness of this information, and the Company has not independently verified this information. The contents hereof should not be construed as investment, legal, tax or other advice and you should consult your own advisers as to legal, business, tax and other related matters concerning an investment in the Company. The Company is not acting on your behalf and does not regard you as a customer or a client. It will not be responsible to you for providing protections afforded to clients or for advising you on the relevant transaction. This presentation also includes certain non-GAAP financial information. We believe that such information is meaningful and useful in understanding the activities and business metrics of the Company's operations. We also believe that these non-GAAP financial measures reflect an additional way of viewing aspects of the Company's business that, when viewed with our International Financial Reporting Standards (IFRS") results, as issued by the International Accounting Standards Board, provide a more complete understanding of factors and trends affecting the Company's business. Further, investors regularly rely on non-GAAP financial measures to assess operating performance and such measures may highlight trends in the Company's business that may not otherwise be apparent when relying on financial measures calculated in accordance with IFRS. We also believe that certain non-GAAP financial measures are frequently used by securities analysts, investors and other interested parties in the evaluation of public companies in the Company's industry, many of which present these measures when reporting their results. The non- GAAP financial information is presented for informational purposes and to enhance understanding of the IFRS financial statements. The non-GAAP measures should be considered in addition to results prepared in accordance with IFRS, but not as a substitute for, or superior to, IFRS results. As other companies may determine or calculate this non-GAAP financial information differently, the usefulness of these measures for comparative purposes is limited. A reconciliation of such non-GAAP financial measures to the nearest GAAP measure is included in this presentation. S5#5TODAY'S PRESENTERS CASSIO BOBSIN FOUNDER & CEO RENATO FRIEDRICH CFO CAIO FIGUEIREDO HEAD OF CORPORATE PLANNING PIERO ROSATELLI INVESTOR RELATIONS 5#626 IA DRIVING THE DISRUPTION OF CUSTOMER EXPERIENCE COMMUNICATIONS Z·E·N·V·I·A#7L 1 Cana KERAPY MOST CUSTOMER COMMUNICATIONS ARE STILL NON-SCALABLE 7#8SAVE TIME V A MAIL BOX DS GET UNITED STATES MAIL, IL MOST CUSTOMER COMMUNICATIONS ARE STILL PHYSICAL#9COYPATINS MOST CUSTOMER COMMUNICATIONS ARE STILL IMPERSONAL 515#10ЛІН PLATFORM THAT TRANSFORMS COMMUNICATIONS FOR THE CUSTOMER EXPERIENCE Z.E.N.V.I.A#11PLATFORM FOR UNIFIED END-TO-END CUSTOMER EXPERIENCE COMMUNICATIONS CHANNELS go TOOLS C SOLUTIONS 11#12BUILDING A LONG TERM VISION FROM THE GROUND UP ENABLING EXPERIENCES ENABLING JOURNEYS ENABLING CONVERSATIONS ENABLING COMMUNICATIONS TIME TODAY VALUE FOR THE END CUSTOMER 04 03 w CUSTOMER IS ENGAGED ALONG THE JOURNEY ON MULTIPLE WAYS 02 CUSTOMER EXPERIENCES A STREAMLINED RELATIONSHIP WITH THE BRAND 01 CUSTOMER CHATS WITH A PERSON/CHATBOT FOR SUPPORT CUSTOMER RECEIVES A MESSAGE OFFERING A PRODUCT 12#1355 BORN IN A GARAGE 04 LAUNCH OF SMS PLATFORM ¹ Pending acquisition upon IPO. 10 LAUNCH OF CAMPAIGN SOLUTION THE EVOLUTION 12 comunika MESSAGING CAPABILITIES 15 spring MESSAGING CAPABILITIES 18 OF A VISION LAUNCH OF COMM FLOW TOOL 19 totalvoice VOICE API LAUNCH OF WHATSAPP API 20 omnize CUSTOMER SERVICE SOLUTION Sirena SALES TEAM SOLUTION LATAM EXPANSION 21 DI¹ ENGAGEMENT SOLUTION SINGLE CUSTOMER JOURNEY 13#14ZENVIA AT A GLANCE NET REVENUE '20¹ R$ 492.5 MILLI MILLION US$ 94.8 MILLION 8^8 ACTIVE CUSTOMERS (20)³ -9,500 NET REVENUE EXPANSION RATE (20)¹ 119.7% REVENUE GROWTH YOY² 28% ACTIVE CUSTOMER CAGR (18-20)³ 27% TAM IN LATIN AMERICA (24)5 USD 4.1 BILLION CAGR 15.4% 20-24 ¹2020 figures consider unaudited proforma financial data for the year ended December 31, 2020, after giving effect from January 1, 2020 to the pending D1 acquisition, Sirena and Smarkio (acquired by D1 in Dec-2020). Considers an average USDBRL FX rate of 5.1975 for 2020. Implicit growth figures consider 2020 proforma net revenues (see 1) vs. 2019 standalone sum of Zenvia, Sirena, D1, and Smarkio net revenues. Figures for Zenvia on a standalone basis. 4TAM according to IDC (2020). 14#15PLATFORM IN LATIN AMERICA FOR CUSTOMER EXPERIENCE COMMUNICATIONS MEXICO 14 EMPLOYEES BASE OPERATIONS IN TOP 3 ECONOMIES 62% OF LATAM GDP PPP CUSTOMERS IN TOP 10 ECONOMIES BY GDP PPP BRAZIL HEADQUARTERS 572 EMPLOYEES' ARGENTINA 63 EMPLOYEES Considers combined 2020 figure, including expected D1 acquisition, for the year ended December 31, 2020. Source: IDC TOTAL ADDRESSABLE MARKET IN LATIN AMERICA ² $2.31B $115.6M $1.548 $659.6M CAGR 15.4% 2020 $4.11B $143.9M $1.808 $2.168 2024 CAGR 20-24 CCM: 5.6% MCM: 4.1% Cpaas: 34.6% 15#16SERVING MARKET LEADERS IN MULTIPLE INDUSTRIES CUSTOMERS PER INDUSTRY Services Commerce Health Education Finance Telco ITP Industries Construction Other CUSTOMER CONCENTRATION (NOF NET REVENUES PRO-FORMA 2020) 65% OTHER CUSTOMERS 35% TOP 10 CUSTOMERS SERVICES 5 OUT OF TOP 10 IN BRAZIL TELECOMM. 4 OUT OF TOP 5 IN BRAZIL RETAIL 6 OUT OF TOP 10 IN BRAZIL BANKS 5 OUT OF TOP 10 IN BRAZIL HEALTHCARE 6 OUT OF TOP 10 IN BRAZIL EDUCATION 5 OUT OF TOP 10 IN BRAZIL INSURANCE 5 OUT OF TOP 10 IN BRAZIL Source: Education: https://especial valor.com.br/valor1000/2020/ranking 1000maiores Other Industries: https://mm.exame.com/malores-empresas-1000/ 16#17DELIVERING STRONG GROWTH W/CAPITAL EFFICIENCY NET REVENUES (RS MILLIONS) 276 2018 17 14 354 2019 492 2020 46% inorganic YOY growth 97 4 93 1020 142 8 115 1Q21 19 109% Yoy growth 23% Voy growth 25% CAGR 18 20 ZENVIA BRAZILI 28% IMPLIED GROWTH 2 (19 - 20) 105% NEW BUSINESS LINES (19-20) ZENVIA STANDALONE D1 STANDALONE ZENVIA PROFORMA SMARKIO AND SIRENA ACQUISTIONS Note: (A) 2020 figures consider unaudited proforma financial data for the year ended December 31, 2020, including expected D1 acquisition and Smarkio (acquired by D1 in Dec-2020); (2) 2019 figures consider standalone Zenvia and D1 with Sirena and Smarkio acquisitions for the year ended December 31, 2019; (C) 2018 figures consider solely standalone Zenvia figures for the year ended December 31, 2018; (D) 1021 and 1020 figures considers unaudited preliminary financial data for Zenvia and D1, at midpoint of expected range in F-1. ¹ Implicit growth figures consider 2020 proforma net revenues (Note A) vs. 2019 standalone sum of Zenvia, Sirena, D1, and Smarkio net revenues Zenvia standalone, consolidating Sirena results from Jan to July 2020 and excludes D1 and Smarkio. Sum of standalone Sirena, D1, and Smarkio net revenues in 2020 vs. 2019 sum of each, respectively. Considers 1021 unaudited preliminary results for Sirena and Smarkio at midpoint of expected range. 17#18Z.E.N.V.I.A PLATFORM EVOLUTION 260#19DISCOVER ATTRACT CONVERT BUY COMPANY 55 8 CUSTOMER SERVE USE NURTURE ENGAGE 19#20PLATFORM FOR UNIFIED END-TO-END CUSTOMER EXPERIENCE COMMUNICATIONS DISCOVER ATTRACT CONVERT BUY CX COMM SOLUTIONS CX COMM TOOLS CX COMM CHANNELS SERVE USE NURTURE ENGAGE 20#21PLATFORM FOR UNIFIED END-TO-END CUSTOMER EXPERIENCE COMMUNICATIONS DISCOVER ATTRACT SMS CONVERT WHATSAPP VOICE BUY CX COMM SOLUTIONS CX COMM TOOLS CX COMM CHANNELS EMAIL SERVE WEBCHAT USE MESSENGER NURTURE RCS ENGAGE 21#22PLATFORM FOR UNIFIED END-TO-END CUSTOMER EXPERIENCE COMMUNICATIONS CONNECTORS DISCOVER ATTRACT ន} ហ API FLOW SMS CONVERT AUTH BOT WHATSAPP VOICE BUY CX COMM SOLUTIONS CX COMM TOOLS CX COMM CHANNELS EMAIL SERVE S JOURNEY WEBCHAT SINGLE CUSTOMER DOCUMENT USE NURTURE MESSENGER INSIGHTS RCS ENGAGE PARTNERS 22#23PLATFORM FOR UNIFIED END-TO-END CUSTOMER EXPERIENCE COMMUNICATIONS CONNECTORS DISCOVER ATTRACT } ហ API FLOW SMS CONVERT CAMPAIGN AUTH BOT WHATSAPP SALES TEAM VOICE BUY CX COMM SOLUTIONS CUSTOMER SERVICE CX COMM TOOLS CX COMM CHANNELS EMAIL SERVE CO JOURNEY ENGAGEMENT WEBCHAT USE SINGLE CUSTOMER DOCUMENT NURTURE MESSENGER INSIGHTS RCS ENGAGE PARTNERS 23#24HOW CUSTOMERS LAND & EXPAND & EXPAND USAGE OVER TIME REVENUES NETI HIGHLY EFFICIENT ACQUISITION STRATEGY TIME CONTINUOUS EXPANSION MULTIPLE OPPORTUNITIES ADDS A BOT TO AUTOMATE CUSTOMER SERVICE ADDS CUSTOMER SERVICE SOLUTION WITH WHATSAPP ADDS RCS TO CAMPAIGN SOLUTION STARTS WITH CAMPAIGN SOLUTION ON SMS CUSTOMER BOT SERVICE CUSTOMER WHATSAPP SERVICE CAMPAIGN CAMPAIGN RCS SMS API 24#25MAJOR INSURANCE COMPANY IN BRAZIL Customer receives an email with PDF proposal Customer learns about the product on WhatsApp chatbot Customer receives a message promoting a product CUSTOMER JOURNEY TRANSFORMATION Customer receives a special offer on SMS to finish acquiring the product CONVERT BUY ATTRACT Customer opt-ins on website for marketing communications Customer receives 2FA code on SMS to confirm an upgrade NURTURE Own SERVE Customer receives an email with welcome kit on PDF Customer received NPS survey to evaluate the service Customer changes invoice payment date over a chatbot Customer chats for support on an acquired product REVENUE EVOLUTION TIME 25#26HIGH TOUCH SALES ENTERPRISE & COMMERCIAL CONSULTATIVE SALES IMPLEMENTATION SUPPORT OUR GO-TO-MARKET oc LOW TOUCH SALES SMALL BUSINESS SELFSERVICE | INSIDE SALES PRODUCT/MKT LED GROWTH 30 CHANNELS ALL SEGMENTS INTEGRATORS RESELL/ADD VALUE SE5 26#27UNIFIED END-TO-END CX COMMUNICATIONS PLATFORM HOW WE WIN EASY TO ADOPT AND SCALE FOR MULTIPLE USE CASES 33 BUSINESS-ORIENTED SALES TARGETING ON THE CUSTOMER JOURNEY TRUSTED PROVIDER WITH SOLID REPUTATION AND RELIABILITY 27#28DEEPENING OUR TECHNOLOGY LEADERSHIP ADD NEW SOFTWARE CAPABILITIES TO REINFORCE OUR UNIQUE POSITION IN CX COMMUNICATIONS CLEAR GROWTH LEVERS USD 4.11bn LatAm 2024¹ USD 2.31bn LatAm 2020¹ USD 95M Zenvia Revenue SCALING OUR LEVERS AHEAD GO-TO-MARKET STRATEGY ACCELERATE CUSTOMER ACQUISITION WITH DIRECT+INDIRECT SALES TO ADDRESS THE HUGE MARKET POTENTIAL INCREASING SPEND WITHIN OUR CUSTOMER BASE IMPROVE CROSS- SELL+UPSELL TO ENABLE MULTIPLE USE CASES WITHIN EACH CUSTOMER ACCELERATE GROWTH VIA M & A ACQUIRE COMPANIES THAT WOULD GENERATE CLEAR SINERGIES WHEN INTEGRATING WITH OUR PLATFORM 1 Source: IDC 2 Derives from our unaudited proforma condensed financial information for the year ended December 31, 2020, which includes the expected D1 acquisition, Sirena and Smarkio (acquired by D1 in Dec 2020); S5 28#29Z.E.N.V.I.A 55 KEY FINANCIAL HIGHLIGHTS#30CONSISTENT CUSTOMER GROWTH 5.871 2018 Note: Figures indicated here are for Zenvia on a standalone basis 27% CAGR 18-20 7.751 2019 ACTIVE CUSTOMERS (#) 9.442 2020 31% YoY 7,803 1Q20 10,191 1Q21 30#3128% IMPLIED GROWTH' 19-20 25% CAGR 18-20 ZENVIA BRAZIL 276 CONSISTENT REVENUE GROWTH & EXPANSION 2018 105% NEW BUSINESS LINES (19-20) 354 NET REVENUES (RS MILLIONS) 2019 17 14 492 97 2020 ZENVIA STANDALONE 93 46% Inorganic YoY growth 142 115 19 1Q21 ZENVIA PROFORMA 18 109% You growth 23% Yoy growth NET REVENUE EXPANSION 117% 100% 2018 117% 1Q20 D1 STANDALONE SMARKIO AND SIRENA ACQUISTIONS Note: (A) 2020 figures consider unaudited proforma financial data for the year ended December 31, 2020, including expected D1 acquisition and Smarkio (acquired by D1 in Dec-2020); (2) 2019 figures consider standalone Zenvia and D1 with Sirena and Smarkio acquisitions for the year ended December 31, 2019; (C) 2018 figures consider solely standalone Zenvia figures for the year ended December 31, 2018, (D) 1021 and 1020 figures considers unaudited preliminary financial data for Zenvia and D1, at midpoint of expected range in F-1. Implicit growth figures consider 2020 proforma net revenues (Note A) vs. 2019 standalone sum of Zenvia, Sirena, D1, and Smarkio net revenues. Zenvia standalone, consolidating Sirena results from Jan to July 2020 and excludes D1 and Smarkio Sum of standalone Sirena, D1, and Smarkio net revenues in 2020 vs 2019 sum of each, respectively. Considers 1021 unaudited preliminary results for Sirena and Smarkio at midpoint of expected range 2019 120% 2020 31#321 GROSS PROFIT & MARGIN (NON GAAP R$ MILLIONS) 33% 90 2018 ZENVIA STANDALONE UNLOCKING HIGH MARGINS POTENTIAL D1 STANDALONE SMARKIO AND SIRENA ACQUISTIONS ZENVIA PROFORMA DI ++ 27% 94 2019 31% 153 2020 28% 28 26 1Q20 31% MARGIN EXPANSION 45 28 1Q21 13 4 26% 3 Note: (A) 2020 figures consider unaudited preliminary proforma financial data for the year ended December 31, 2020, including expected D1 acquisition and Smarkio (acquired by D1 in Dec-2020); (2) 2019 figures consider standalone Zenvia, Sirena, D1, and Smarkio figures for the year ended December 31, 2019; (C) 2018 figures consider solely standalone Zenvia figures for the year ended December 31, 2018. (D) 1021 and 1020 figures considers unaudited preliminary financial data for Zenvia and D1, including amortization of intangible assets acquired from business combinations of each at midpoint of expected range in F-1. ZENVIA BRAZIL² NEW BUSINESS LINES GROSS MARGIN (NON GAAP - R$ MILLIONS) (2020) Sirena 73% 2020 DI SMARKIO 67% 2020 28% % of Total Gross Profit (2020) 68% NEW BUSINESS LINES (2020) Considers 1021 unaudited preliminary results for Smarkio and Sirena at midpoint of expected range. Zenvia standalone, consolidating Sirena results from Jan to July 2020 and excludes D1 and Smarkio. Sum of Sirena, D1, and Smarkio 20 non-gaap gross profit + the sum of net revenues for each 32#3316% ■ 45 ADJ. EBITDA & MARGIN (RS MILLIONS) 2018 10% SUSTAINING PROFITABILITY 36 2019 1% 3 2020 ZENVIA STANDALONE ✓ PROVEN PLATFORM PROFITABILITY RECAP TO REINVEST IN GROWTH LARGE MARKET OPPORTUNITY LEADING TO STRONG S&M / R&D INVESTMENTS ZENVIA PROFORMA Note: (A) 2020 figures consider unaudited proforma financial data for the year ended December 31, 2020, including expected D1 acquisition and Smarkio (acquired by D1 in Dec-2020), (2) 2019 figures consider standalone Zenvia, Sirena, D1, and Smarkio figures for the year ended December 31, 2019, (C) 2018 figures consider solely standalone Zenvia figures for the year ended December 31, 2018 33#34MID TERM OBJECTIVES REVENUE GROWTH¹ GROSS MARGIN ADJ. EBITDA MARGIN 2020 PRO FORMA 28% 31% 1% MID-TERM OBJECTIVES 30 45 - 35% 50% 15 - 20% Note: These targets are forward looking, are subject to significant uncertainties and contingencies and are based upon assumptions with respect to future decisions and operating results, which are subject to change. Actual results will vary and those variations are material and may cause us not to achieve these goals. For a discussion of some of the important factors that could cause these variations, please consult the "Risk Factors" section of the preliminary prospectus. Long term model metrics are non-GAAP. Refer to the appendix for a reconciliation of non-GAAP financial measures to the most comparable GAAP metrics Implicit growth figures consider 2020 proforma net revenues (see 1) vs. 2019 standalone sum of Zenvia, Sirena, D1, and Smarkio net revenues. PET SE5 34#35ATTRACTION EMPLOYER BRANDING RECRUITER TEAM CANDIDATE EXPERIENCE TOP Great Place 70 To IT MEDIUM Work® IN BRAZIL (2020) OUR PEOPLE STRATEGY ENGAGEMENT CULTURE AS A PROCESS DIVERSITY & INCLUSION FLEXIBILITY & ACCOUNTABILITY TEAM | LEADERSHIP MALE FEMALE 55% 45% DEVELOPMENT CLEAR CAREER PATH COMPETITIVE RECOGNITION HIGH TALENT DENSITY RET SE 35#362F F ZE.NVIA

Download to PowerPoint

Download presentation as an editable powerpoint.

Related

Fiscal 3Q Investor Presentation image

Fiscal 3Q Investor Presentation

Healthcare

FY23 Full-Year Results Presentation image

FY23 Full-Year Results Presentation

Healthcare

Healthcare Network P&L Statement and Expansion Projects image

Healthcare Network P&L Statement and Expansion Projects

Healthcare

Accreditation and Quality Assurance Overview image

Accreditation and Quality Assurance Overview

Healthcare

Investment Highlights image

Investment Highlights

Healthcare

Investor Presentation image

Investor Presentation

Healthcare

IDEAYA Biosciences Interim IDE397 Phase 1 Clinical Data and Q1 2022 Corporate Update image

IDEAYA Biosciences Interim IDE397 Phase 1 Clinical Data and Q1 2022 Corporate Update

Healthcare

BioAtla Investor Presentation Deck image

BioAtla Investor Presentation Deck

Healthcare